Navigation Links
Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance
Date:5/3/2011

$

27,759$

30,765Interest received

$

2,594$

15,891Income taxes paid

$

83,494$

50,231Income taxes refunded

$

1,303$

1,159See accompanying notes to condensed consolidated financial statements.Table IPERRIGO COMPANYRECONCILIATION OF NON-GAAP MEASURES(in thousands, except per share amounts)(unaudited)Three Months EndedConsolidatedMarch 26, 2011March 27, 2010% ChangeGAAPNon-GAAP AdjustmentsAs AdjustedGAAPNon-GAAP AdjustmentsAs AdjustedGAAPAs AdjustedNet sales

$
91,563$
-$
91,563$
537,632$
-$
537,63229 %29 %Cost of sales

452,4817,703

(a)

444,778350,2374,322

(a,d)

345,91529 %29 %Gross profit

239,0827,703246,785187,3954,322191,71728 %29 %Operating expensesDistribution

8,525-8,5257,919-7,9198 %8 %Research and development

23,511-23,51117,715-17,71533 %33 %Selling and administration

84,1335,095

(a,b)

79,03865,1354,198

(a,e)

60,93729 %30 %Restructuring

---7,4747,474

(f)

-(100)%-Total

116,1695,095111,07498,24311,67286,571Operating income

122,91312,798135,71189,15215,994105,14638 %29 %Interest, net

10,915-10,9155,927700

(g)

5,22784 %109 %Other income, net

(753)-(753)(1,367)-(1,367)(45)%(45)%Income from continuing operations before income taxes

112,75112,798125,54984,59216,694101,28633 %24 %Income tax expense

21,2204,117

(c)

25,33723,0512,808

(c)

25,859(8)%(2)%Income from continuing operations

$
91,531$
8,681$
,212$
,541$
3,886$
75,42749 %33 %Diluted earnings per share from continuing operations

$
.98$
.07$
.66$
.8148 %32 %Diluted weighted average shares outstanding

93,54993,54992,58992,589Selected ratios as a percentage of net salesGross profit

34.6 %35.7 %34.9 %35.7 %Operating expenses

16.8 %16.1 %18.3 %16.1 %Operating inc
'/>"/>

SOURCE Perrigo Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Perrigo Announces FDA Final Approval for Minoxidil Foam - Generic Equivalent to Mens Rogaine® Foam
2. Perrigo Company Announces Quarterly Dividend
3. Perrigos PBM Infant Formula Unit Wins Appellate Judgment Versus Mead Johnson
4. Perrigo Partner Teva Receives Final OTC Approval for Sales and Distribution of Fexofenadine HCl 60 mg and 180 mg Tablets
5. Perrigo Announces Conclusion of the FDA Re-Inspection
6. Perrigo Company to Present at the Barclays Capital 2011 Global Health Care Conference
7. Perrigo Announces Arrival of the FDA for Reinspection Related to the Allegan Facility Warning Letter
8. Perrigo Company to Present at the Citi 2011 Global Health Care Conference
9. Perrigo Confirms Filing for Generic Version of Taclonex® Ointment and Announcement of Lawsuit by Leo Pharma
10. Perrigo Enters Into Exclusive Sales and Distribution Agreement With AgaMatrix for Store Brand Blood Glucose Monitoring Products
11. Perrigo Announces Settlement of Rogaine® Foam Patent Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , Sept. 30, 2014 STUDY OBJECTIVES ... study is to provide an overview of the ... for protein drugs/therapeutics. The key objective is to ... protein drugs as an important tool in the ... present and future strategies within the protein therapeutics ...
(Date:9/30/2014)... DENVER , Sept. 30, 2014  According ... "the world of cancer clinical trials is going ... clinical trials and the work of the current ... these types of ,next generation, clinical trials, which ... tomorrow."  The company has been ...
(Date:9/30/2014)... -- The Chinese wound care market is in the ... incidence of lifestyle diseases, coupled with the increase in ... quality of wound care products provide the impetus for ... health insurance schemes and increased reimbursement rate for wound ... findings of primary and secondary researches, this research service ...
Breaking Medicine Technology:Global Markets and Manufacturing Technologies for Protein Drugs -- Focus on Cytokines and Monoclonal Antibodies 2Global Markets and Manufacturing Technologies for Protein Drugs -- Focus on Cytokines and Monoclonal Antibodies 3Global Markets and Manufacturing Technologies for Protein Drugs -- Focus on Cytokines and Monoclonal Antibodies 4Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2China Wound Care Market 2China Wound Care Market 3
(Date:9/30/2014)... 2014 Integrated Medicine Alliance , ... another new medical specialty practice through a unique partnership ... will be located within the company’s Shrewsbury location and ... Isaac Tawfik of American Heart Center, P.C., a highly ... will offer Integrated Medicine Alliance patients top notch cardiovascular ...
(Date:9/30/2014)... been awarded a three-year $1.7 million grant from ... new imaging technologies and data analysis techniques that ... of neurons in the brain interact to process ... the precise interactions between millions of nerve cells ... alterations in these interactions that may be responsible ...
(Date:9/30/2014)... September 30, 2014 Elevate , the ... perform better in and out of the gym by providing ... caught the attention of Shane Michaels, prompting an investigative review. ... is the reason most people simply just don’t have the ... staying focused at work, getting the motivation to finish a ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Hospice ... its annual “In Celebration” gala, honoring three outstanding ... mission of striving to provide extraordinary and dignified ... facing a serious or life-limiting illness. , The ... in Rye, NY and recognized William (Bill) J. ...
(Date:9/30/2014)... Dr. Karl R.O.S. Johnson, DC, has developed ... care that is dramatically improving the health and lives ... & Nutrition—applies a proprietary, multi-dimensional approach that goes beyond ... of inflammation, neurology of the joint and neurology of ... brain to the spine, to the legs, knees and ...
Breaking Medicine News(10 mins):Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2Health News:UMD receives inaugural BRAIN Initiative Award 2Health News:Elevate: Review Exposes Blue Star Nutraceutical’s Latest Supplement for Ultimate Brain Function, Focus, and Energy 2Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 3
... suggests weight loss may be an early sign of ... before the onset of // definite dementia symptoms and ... in the elderly is common and may be associated ... in people who already have dementia. For the study ...
... researchers have linked breathing cancer-causing compounds during pregnancy // ... They also believe that nearly all childhood cancers can ... noxious substances. ,The study compared a chemical emissions ... died from leukemia and other cancers between 1968 and ...
... the New Year has brought with it a new lease ... For these //patients the uphill struggle doesn’t stop with finding ... , Research has shown that despite all high tech ... a common phenomenon. Transplant surgeon Ignazio Marino, M.D., of Thomas ...
... hormones could be responsible for some of the problems ... measuring levels of five different sex hormones in men ... those found in healthy people. All the MS patients ... brain damage characteristic of the disease. ,Results showed ...
... the use of estrogen replacement therapy with a lower risk ... is known as a good indicator of exposure to estrogen. ... BMD related to the risk of cognitive problems. All of ... of the study. Researchers then measured their BMD at several ...
... a recent study researchers say estrogen may provide protection ... different diets to female mice and followed their progress for ... of specific ingredients.// ,Diet one contained milk protein, and ... of estrogen. The other three diets contained soy protein with ...
Cached Medicine News:
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: